Location History:
- San Diego, CA (US) (1988 - 2000)
- El Cajon, CA (US) (1995 - 2008)
Company Filing History:
18 out of 48 
12 out of 4,770 
7 out of 22 
Years Active: 1988-2008
Areas of Expertise:
Title: Michael Miller Harpold: Innovator in Neuronal Biology
Introduction
Michael Miller Harpold, based in El Cajon, California, is a distinguished inventor with an impressive portfolio of 46 patents. His innovative contributions primarily focus on human calcium channels and nicotinic acetylcholine receptors, showcasing the intersection between molecular biology and therapeutic advancements.
Latest Patents
Harpold’s latest patents include groundbreaking compositions and methods related to human calcium channels. One notable patent describes isolated DNA encoding each of the human calcium channel α, β, and γ subunits, including splice variants of primary transcripts. This invention also encompasses cells and vectors containing the DNA, along with methods to identify compounds that modulate the activity of human calcium channels. Another significant patent involves DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits. It details methods for producing isolated or substantially pure alpha and beta subunits and highlights possible combinations of these subunits for enhanced functionality.
Career Highlights
Throughout his career, Michael has made substantial contributions to the field of neuroscience and pharmacology. He has worked with prominent organizations, including Sibia Neurosciences, Inc. and Merck & Company, Inc., where he has played a vital role in advancing research and product development related to neuronal receptors and calcium channels.
Collaborations
Harpold has collaborated with notable professionals in the field, including his coworkers Steven B. Ellis and Mark E. Williams. These partnerships highlight the collaborative nature of scientific innovation and the importance of teamwork in advancing research.
Conclusion
Michael Miller Harpold stands out as a prolific inventor whose work addresses critical aspects of neuronal activity and pharmacological intervention. His extensive patent portfolio not only reinforces his status as a leading innovator but also contributes significantly to the scientific community's understanding of complex biological systems.